Organization | Marquette University

Marquette University Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Milwaukee WI United States (1881)

Organization Overview

First Clinical Trial

2005

NCT00147368

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Marquette University | Marquette University, College of Nursing | MSHR

Active Ingredients

Drugs in Phase 4 Trials (2)

acetaminophen (tylenol) (1 trial)

ibuprofen (motrin) (1 trial)

Drugs in Phase 2 Trials (4)

arginine (1 trial)

bifidobacterium animalis (1 trial)

bifidobacterium longum (1 trial)

Lactobacillus acidophilus (1 trial)

Drugs in Other Trials (4)

beetroot juice (1 trial)

lactobacillus reuteri (1 trial)

lactobacillus rhamnosus (1 trial)

menthol (Salonpas) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malaria (Phase 2)

Malaria, Falciparum (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial APIs: 10